secwatch.observer — SEC 8-K summary
======================================

Issuer:     RIGEL PHARMACEUTICALS INC (RIGL)
CIK:        0001034842
Form:       8-K
Filed at:   2023-11-30T23:59:59+00:00
Accession:  0001104659-23-122171
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Rigel Pharma gets Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------

- Received Nasdaq deficiency letter on Nov 27, 2023 for bid price below $1.00 for 30 consecutive business days.
- Has 180 calendar days, until May 28, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by May 28, may be eligible for additional 180-day period if transfers to Nasdaq Capital Market.
- Company may consider a reverse stock split to cure deficiency; no immediate effect on listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1034842/000110465923122171/0001104659-23-122171-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1034842/000110465923122171/tm2331763d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-122171

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer